Impact BioMedical Correlations

IBO Stock

USD 0.64 0.23 57.17%

The current 90-days correlation between Impact BioMedical and Neurosense Therapeutics is -0.02 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Impact BioMedical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Impact BioMedical moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Impact BioMedical Correlation With Market

Good diversification

The correlation between Impact BioMedical and DJI is -0.09 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Impact BioMedical and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Impact Stock

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impact BioMedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical guide.

Moving against Impact Stock

0.52	VALN	Valneva SE ADR	Pair Corr
0.47	DNTH	Dianthus Therapeutics Buyout Trend	Pair Corr
0.39	DNLI	Denali Therapeutics	Pair Corr
0.36	JUMP	Leveljump Healthcare Corp	Pair Corr
0.31	8VP1	AVRICORE HEALTH INC	Pair Corr
0.52	SAB	Sonic Healthcare	Pair Corr
0.51	AVH	Avita Medical	Pair Corr
0.45	SABSW	SAB Biotherapeutics	Pair Corr
0.38	PYC	Physiomics Plc	Pair Corr
0.35	6C1	CytomX Therapeutics Earnings Call Today	Pair Corr
0.46	NANO	Nanobiotix SA	Pair Corr
0.39	DVAX	Dynavax Technologies	Pair Corr

Related Correlations Analysis

	NRSN	AIM	BCLI	TCRT	MLEC	CYCN	QNRX	ADIL	XTLB	XBIO
NRSN		0.26	0.05	-0.17	-0.06	0.26	0.33	0.29	0.35	0.44	NRSN
AIM	0.26		-0.31	0.48	-0.38	0.57	0.7	0.87	-0.04	0.06	AIM
BCLI	0.05	-0.31		0.1	0.17	-0.1	0.03	-0.09	-0.11	0.37	BCLI
TCRT	-0.17	0.48	0.1		-0.21	0.55	0.48	0.61	-0.4	0.09	TCRT
MLEC	-0.06	-0.38	0.17	-0.21		-0.2	-0.34	-0.58	0.09	0.31	MLEC
CYCN	0.26	0.57	-0.1	0.55	-0.2		0.51	0.65	-0.27	0.26	CYCN
QNRX	0.33	0.7	0.03	0.48	-0.34	0.51		0.74	-0.38	0.12	QNRX
ADIL	0.29	0.87	-0.09	0.61	-0.58	0.65	0.74		-0.15	0.19	ADIL
XTLB	0.35	-0.04	-0.11	-0.4	0.09	-0.27	-0.38	-0.15		0.26	XTLB
XBIO	0.44	0.06	0.37	0.09	0.31	0.26	0.12	0.19	0.26		XBIO
	NRSN	AIM	BCLI	TCRT	MLEC	CYCN	QNRX	ADIL	XTLB	XBIO

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ADIL	+ 0.87	AIM
ADIL	+ 0.74	QNRX
QNRX	+ 0.7	AIM
ADIL	+ 0.65	CYCN
ADIL	+ 0.61	TCRT
CYCN	+ 0.57	AIM

High negative correlations

ADIL	- 0.58	MLEC
XTLB	- 0.4	TCRT
XTLB	- 0.38	QNRX
MLEC	- 0.38	AIM
QNRX	- 0.34	MLEC
BCLI	- 0.31	AIM

Risk-Adjusted Indicators

There is a big difference between Impact Stock performing well and Impact BioMedical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Impact BioMedical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
NRSN	4.11	(0.31)	0.00	(0.25)	0.00	0.00	8.51	(7.37)	28.83
AIM	5.46	(0.84)	0.00	(1.10)	0.00	0.00	7.69	(11.94)	73.61
BCLI	4.31	0.38	0.05	(0.23)	4.57	(5.61)	12.50	(7.02)	24.01
TCRT	4.05	0.06	0.02	0.06	5.40	(4.08)	9.82	(9.52)	24.31
MLEC	11.95	2.31	0.19	0.73	11.27	(15.87)	47.61	(22.78)	152.55
CYCN	4.39	0.02	0.01	0.05	5.40	(5.68)	8.87	(10.53)	55.81
QNRX	5.53	(0.93)	0.00	0.63	0.00	0.00	10.80	(10.99)	42.12
ADIL	3.27	(1.94)	0.00	(2.84)	0.00	0.00	4.72	(9.04)	34.48
XTLB	4.88	0.34	0.05	0.52	5.56	(6.34)	8.25	(10.53)	69.50
XBIO	3.23	(0.03)	0.00	(0.02)	0.00	0.00	6.14	(6.84)	23.67

Impact BioMedical Corporate Executives

Elected by the shareholders, the Impact BioMedical's board of directors comprises two types of representatives: Impact BioMedical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Impact. The board's role is to monitor Impact BioMedical's management team and ensure that shareholders' interests are well served. Impact BioMedical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Impact BioMedical's outside directors are responsible for providing unbiased perspectives on the board's policies.

Todd CPA

Secretary CFO

Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC